Literature DB >> 3190547

Photochemical initiation of thrombosis. Fluorescein angiographic, histologic, and ultrastructural alterations in the choroid, retinal pigment epithelium, and retina.

A J Royster1, S K Nanda, D L Hatchell, J S Tiedeman, J J Dutton, M C Hatchell.   

Abstract

A new method of producing vascular occlusion, photochemical activation of intravenously injected rose bengal, was used to produce experimental thrombosis of the preretinal and choroidal blood vessels in rabbit eyes. Fluorescein angiography and light and electron microscopy were used to describe the resultant pathologic alterations over time. As early as one hour after treatment, the endothelium of both preretinal and choroidal blood vessels was severely damaged or completely obliterated, and platelet aggregates occluded the vascular lumina. Occlusion of the preretinal and choroidal blood vessels persisted for up to three days; however, endothelial regeneration and reperfusion had occurred in both vascular beds by seven days. In addition, the retinal pigment epithelium and myelin wings suffered ischemic damage. The retinal pigment epithelium began to recover by seven days, but the myelin wings appeared to be irreversibly damaged.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3190547     DOI: 10.1001/archopht.1988.01060140776054

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  12 in total

1.  Ultrasound enhanced thrombolysis in experimental retinal vein occlusion in the rabbit.

Authors:  J Larsson; J Carlson; S B Olsson
Journal:  Br J Ophthalmol       Date:  1998-12       Impact factor: 4.638

2.  Occlusion of retinal vessels using targeted delivery of a platelet aggregating agent.

Authors:  Y Ogura; T Guran; K Takahashi; R Zeimer
Journal:  Br J Ophthalmol       Date:  1993-04       Impact factor: 4.638

3.  Optical coherence tomography angiography of retinal vascular occlusions produced by imaging-guided laser photocoagulation.

Authors:  Brian T Soetikno; Xiao Shu; Qi Liu; Wenzhong Liu; Siyu Chen; Lisa Beckmann; Amani A Fawzi; Hao F Zhang
Journal:  Biomed Opt Express       Date:  2017-07-07       Impact factor: 3.732

4.  Corneal neovascularization in rats as a model for photothrombotic therapy using bacteriochlorin a and an argon laser.

Authors:  C A van Gool; H J Schuitmaker; M J Jager
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-07       Impact factor: 3.117

5.  Higher irradiance and photodynamic therapy for age-related macular degeneration (an AOS thesis).

Authors:  Joan W Miller
Journal:  Trans Am Ophthalmol Soc       Date:  2008

6.  Evaluation of ultrasound-assisted thrombolysis using custom liposomes in a model of retinal vein occlusion.

Authors:  Walid F Abdallah; Hitenkumar Patel; Edward G Grant; Bruno Diniz; Gerald J Chader; Mark S Humayun
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-05       Impact factor: 4.799

7.  A zebrafish retinal graded photochemical stress model.

Authors:  Joseph W Eichenbaum; Ayca Cinaroglu; Kenneth D Eichenbaum; Kirsten C Sadler
Journal:  J Pharmacol Toxicol Methods       Date:  2009-03-05       Impact factor: 1.950

8.  Increased retinal toxicity of intravitreal tissue plasminogen activator in a central retinal vein occlusion model.

Authors:  Takuhiro Yamamoto; Motohiro Kamei; Paradee Kunavisarut; Mihoko Suzuki; Yasuo Tano
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-10-25       Impact factor: 3.117

9.  Natural course of experimental retinal vein occlusion in rabbit; arterial occlusion following venous photothrombosis.

Authors:  Hossein Ameri; Tanapat Ratanapakorn; Narsing A Rao; Gerald J Chader; Mark S Humayun
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-07-19       Impact factor: 3.117

10.  Histological findings of a surgically excised myopic choroidal neovascular membrane after photodynamic therapy. A case report.

Authors:  A Scupola; L Ventura; A C Tiberti; D D'Andrea; E Balestrazzi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-02-17       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.